Mario Fabri

8.5k total citations
58 papers, 1.3k citations indexed

About

Mario Fabri is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Mario Fabri has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 18 papers in Epidemiology and 14 papers in Infectious Diseases. Recurrent topics in Mario Fabri's work include Immune Cell Function and Interaction (10 papers), Mycobacterium research and diagnosis (7 papers) and Immunotherapy and Immune Responses (7 papers). Mario Fabri is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Mycobacterium research and diagnosis (7 papers) and Immunotherapy and Immune Responses (7 papers). Mario Fabri collaborates with scholars based in Germany, United States and Switzerland. Mario Fabri's co-authors include Robert L. Modlin, Andrea Sommer, Stephan R. Krutzik, Philip T. Liu, Mirjam Schenk, Heiko Bruns, Steffen Stenger, Alexander Stephan, Matthew Wheelwright and John S. Adams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Mario Fabri

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Fabri Germany 20 489 335 293 264 237 58 1.3k
Christina E. Zielinski Germany 20 1.2k 2.5× 426 1.3× 237 0.8× 170 0.6× 226 1.0× 41 1.9k
Afsaneh Soruri Germany 20 753 1.5× 355 1.1× 129 0.4× 177 0.7× 110 0.5× 28 1.3k
R. Andrés Floto United Kingdom 10 665 1.4× 422 1.3× 193 0.7× 209 0.8× 190 0.8× 14 1.3k
Carlene L. Zindl United States 14 1.3k 2.6× 426 1.3× 203 0.7× 103 0.4× 159 0.7× 20 1.9k
Chad Storer United States 12 414 0.8× 516 1.5× 314 1.1× 76 0.3× 299 1.3× 18 1.5k
Valeria Brazzelli Italy 21 491 1.0× 184 0.5× 264 0.9× 157 0.6× 54 0.2× 135 1.4k
J. Riggert Germany 25 479 1.0× 387 1.2× 224 0.8× 95 0.4× 107 0.5× 75 1.8k
Giovanni Carulli Italy 18 309 0.6× 277 0.8× 88 0.3× 314 1.2× 163 0.7× 121 1.4k
Michail Schizas United States 16 623 1.3× 531 1.6× 141 0.5× 128 0.5× 133 0.6× 17 1.4k
Jan‐Michel Otte Germany 18 772 1.6× 380 1.1× 168 0.6× 143 0.5× 68 0.3× 29 1.6k

Countries citing papers authored by Mario Fabri

Since Specialization
Citations

This map shows the geographic impact of Mario Fabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Fabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Fabri more than expected).

Fields of papers citing papers by Mario Fabri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Fabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Fabri. The network helps show where Mario Fabri may publish in the future.

Co-authorship network of co-authors of Mario Fabri

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Fabri. A scholar is included among the top collaborators of Mario Fabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Fabri. Mario Fabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burmester, Anke, Silke Uhrlaß, Mario Fabri, et al.. (2025). Significant Impact of Growth Medium on Itraconazole Susceptibility in Azole-Resistant Versus Wild-Type Trichophyton indotineae, rubrum, and quinckeanum Isolates. International Journal of Molecular Sciences. 26(15). 7090–7090. 1 indexed citations
2.
Günther, Albrecht, Anke Burmester, Mario Fabri, Jörg Tittelbach, & Cornelia Wiegand. (2025). Co-Treatment with Ritonavir or Sertraline Enhances Itraconazole Efficacy Against Azole-Resistant Trichophyton indotineae Isolates. Journal of Fungi. 11(10). 698–698.
3.
Kubacki, Torsten, et al.. (2025). Kutane Manifestationen der Sarkoidose. Die Dermatologie. 76(4). 231–243.
4.
Rasokat, H, et al.. (2023). Humane Affenpocken (Mpox). Die Dermatologie. 75(1). 40–47. 1 indexed citations
5.
Lehmann, Clara, et al.. (2023). Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis. Journal of Infection and Public Health. 16(6). 955–963. 2 indexed citations
6.
Fabri, Mario, et al.. (2022). Weichgewebeinfektionen. Der Hautarzt. 73(3). 223–233. 1 indexed citations
7.
Grzes, Katarzyna M., Nir Yogev, Erika L. Pearce, et al.. (2021). Tofacitinib Suppresses IL-10/IL-10R Signaling and Modulates Host Defense Responses in Human Macrophages. Journal of Investigative Dermatology. 142(3). 559–570.e6. 8 indexed citations
8.
Grzes, Katarzyna M., David E. Sanin, Agnieszka M. Kabat, et al.. (2021). Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters. Immunity. 54(11). 2514–2530.e7. 46 indexed citations
9.
Fabri, Mario, Matteo Villa, Michal A. Stanczak, et al.. (2021). Research Techniques Made Simple: Profiling Cellular Energy Metabolism. Journal of Investigative Dermatology. 141(12). 2767–2774.e2. 4 indexed citations
10.
Kromer, Christian, Mario Fabri, Christoph Schlapbach, et al.. (2019). Diagnosis of mycobacterial skin infections. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 17(9). 889–893. 7 indexed citations
11.
Rasokat, H, et al.. (2019). Exantheme nach Auslandsreisen. Der Hautarzt. 70(11). 897–913. 2 indexed citations
12.
Fabri, Mario, et al.. (2017). Atypische Mykobakterien. Der Hautarzt. 68(5). 403–411. 3 indexed citations
13.
Steiger, Julia, Alexander Stephan, Megan S. Inkeles, et al.. (2016). Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette–Guérin in Glucocorticoid-Treated Human Macrophages. The Journal of Immunology. 197(1). 222–232. 20 indexed citations
14.
Stephan, Alexander, Julia Steiger, Pia Hartmann, et al.. (2016). 318 LL37:DNA complexes provide antimicrobial activity against intracellular bacteria in human macrophages. Journal of Investigative Dermatology. 136(9). S215–S215.
15.
Sommer, Andrea & Mario Fabri. (2015). Vitamin D Regulates Cytokine Patterns Secreted by Dendritic Cells to Promote Differentiation of IL-22-Producing T Cells. PLoS ONE. 10(6). e0130395–e0130395. 45 indexed citations
16.
Stephan, Alexander & Mario Fabri. (2014). The NET , the trap and the pathogen: neutrophil extracellular traps in cutaneous immunity. Experimental Dermatology. 24(3). 161–166. 23 indexed citations
17.
Schlaak, Max, et al.. (2012). Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene. Case Reports in Dermatology. 4(1). 56–60. 4 indexed citations
18.
Sieling, Peter A., Preston J. Hill, Karen M. Dobos, et al.. (2008). Conserved Mycobacterial Lipoglycoproteins Activate TLR2 but Also Require Glycosylation for MHC Class II-Restricted T Cell Activation. The Journal of Immunology. 180(9). 5833–5842. 26 indexed citations
19.
Stephen, Tom L., Mario Fabri, Till A. Röhn, et al.. (2007). Transport of Streptococcus pneumoniae Capsular Polysaccharide in MHC Class II Tubules. PLoS Pathogens. 3(3). e32–e32. 21 indexed citations
20.
Fabri, Mario & Nicolas Hunzelmann. (2007). Differential diagnosis of scleroderma and pseudoscleroderma. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 5(11). 977–983. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina E. Zielinski Breakdown of academic impact, for papers by Afsaneh Soruri Breakdown of academic impact, for papers by R. Andrés Floto Breakdown of academic impact, for papers by Carlene L. Zindl Breakdown of academic impact, for papers by Chad Storer Breakdown of academic impact, for papers by Valeria Brazzelli Breakdown of academic impact, for papers by J. Riggert Breakdown of academic impact, for papers by Giovanni Carulli Breakdown of academic impact, for papers by Michail Schizas Breakdown of academic impact, for papers by Jan‐Michel Otte
Rankless by CCL
2026